Baselake Partners, LP

13D and 13G Filings

13D/G filings: 13G on 8 securities
Location: Troy, MI
CIK: 0001957912
Alternate names: Huron Associates, LP
Form D filings: 5 filings
All SEC filings: View on sec.gov

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Kiora Pharmaceuticals, Inc. 13G KPRX · 49721T507	KPRX	49721T507	5.8%	257,500	13G	9/17/2026 Event 9/10/2026
Baselake Partners, LP			5.8%	257,500
Baselake Management, LLC			5.8%	257,500
David Paolella			5.8%	257,500
TherapeuticsMD, Inc. 13G/A Amendment 1 TXMD · 88338N206	TXMD	88338N206	6.8%	790,703	13G/A Amendment 1	8/5/2026 Event 6/30/2026
Baselake Partners, LP			6.8%	790,703
Baselake Management, LLC			6.8%	790,703
David Paolella			6.8%	790,703
Passage Bio, Inc. 13G PASG · 702712209	PASG	702712209	7.3%	235,058	13G	6/25/2026 Event 6/18/2026
Baselake Partners, LP			7.3%	235,058
Baselake Management, LLC			7.3%	235,058
David Paolella			7.3%	235,058
Kezar Life Sciences, Inc. 13G/A Amendment 2 KZR · 49372L209	KZR	49372L209	0%	0	13G/A Amendment 2	5/28/2026 Event 5/11/2026
Baselake Partners, LP			0%	0
Baselake Management, LLC			0%	0
David Paolella			0%	0
Kezar Life Sciences, Inc. 13G/A Amendment 1 KZR · 49372L209	KZR	49372L209	0%	391,862	13G/A Amendment 1	5/12/2026 Event 5/11/2026
Baselake Partners, LP			0%	0
Baselake Management, LLC			0%	0
David Paolella			0%	391,862
TherapeuticsMD, Inc. 13G TXMD · 88338N206	TXMD	88338N206	5.2%	607,181	13G	4/6/2026 Event 3/30/2026
Baselake Partners, LP			5.2%	607,181
Baselake Management, LLC			5.2%	607,181
David Paolella			5.2%	607,181
Kezar Life Sciences, Inc. 13G KZR · 49372L209	KZR	49372L209	5.3%	391,862	13G	4/6/2026 Event 3/30/2026
Baselake Partners, LP			5.3%	391,862
Baselake Management, LLC			5.3%	391,862
David Paolella			5.3%	391,862
Generation Bio Co. 13G/A Amendment 1 GBIO · 37148K209	GBIO	37148K209	0%	0	13G/A Amendment 1	2/11/2026 Event 2/9/2026
Baselake Partners, LP			0%	0
Baselake Management, LLC			0%	0
David Paolella			0%	0
Generation Bio Co. 13G GBIO · 37148K209	GBIO	37148K209	5.2%	350,000	13G	2/6/2026 Event 2/5/2026
Baselake Partners, LP			5.2%	350,000
Baselake Management, LLC			5.2%	350,000
David Paolella			5.2%	350,000
LeonaBio, Inc. f.k.a. Athira Pharma, Inc. 13G/A Amendment 1 LONA · 04746L203	LONA	04746L203	1.9%	75,789	13G/A Amendment 1	2/6/2026 Event 12/31/2025
Baselake Partners, LP			1.9%	75,789
Baselake Management, LLC			1.9%	75,789
David Paolella			1.9%	75,789
Neuphoria Therapeutics Inc. 13G/A Amendment 1 NEUP · 64136E102	NEUP	64136E102	4.1%	222,222	13G/A Amendment 1	2/6/2026 Event 12/31/2025
Baselake Partners, LP			4.1%	222,222
Baselake Management, LLC			4.1%	222,222
David Paolella			4.1%	222,222
Synlogic, Inc. 13G SYBX · 87166L209	SYBX	87166L209	9.7%	1,140,000	13G	1/23/2026 Event 1/20/2026
Baselake Partners, LP			9.7%	1,140,000
Baselake Management, LLC			9.7%	1,140,000
David Paolella			9.7%	1,140,000
Athira Pharma, Inc. 13G LONA · 04746L203	LONA	04746L203	5.0%	197,481	13G	11/14/2025 Event 11/7/2025
Baselake Partners, LP			5.0%	197,481
Baselake Management, LLC			5.0%	197,481
David Paolella			5.0%	197,481
Neuphoria Therapeutics Inc. 13G NEUP · 64136E102	NEUP	64136E102	9.4%	222,222	13G	10/31/2025 Event 10/27/2025
Baselake Partners, LP			9.4%	222,222
Baselake Management, LLC			9.4%	222,222
David Paolella			9.4%	222,222

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.